{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:48:14Z","timestamp":1794566894879,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>PAX5 and EBF1 work synergistically to regulate genes that are involved in B lymphocyte differentiation. We used the KIS-1 diffuse large B cell lymphoma cell line, which is reported to have elevated levels of PAX5 expression, to investigate the mechanism of EBF1- and PAX5-regulated gene expression. We demonstrate the lack of expression of hallmark B cell genes, including <jats:italic>CD19<\/jats:italic>, <jats:italic>CD79b<\/jats:italic>, and <jats:italic>EBF1<\/jats:italic>, in the KIS-1 cell line. Upon restoration of EBF1 expression we observed activation of <jats:italic>CD19<\/jats:italic>, <jats:italic>CD79b<\/jats:italic> and other genes with critical roles in B cell differentiation. Mass spectrometry analyses of proteins co-immunoprecipitated with PAX5 in KIS-1 identified components of the MLL H3K4 methylation complex, which drives histone modifications associated with transcription activation. Immunoblotting showed a stronger association of this complex with PAX5 in the presence of EBF1. Silencing of KMT2A, the catalytic component of MLL, repressed the ability of exogenous EBF1 to activate transcription of both <jats:italic>CD19<\/jats:italic> and <jats:italic>CD79b<\/jats:italic> in KIS-1 cells. We also find association of PAX5 with the MLL complex and decreased CD19 expression following silencing of KMT2A in other human B cell lines. These data support an important role for the MLL complex in PAX5-mediated transcription regulation.<\/jats:p>","DOI":"10.1038\/s41598-021-81000-5","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T11:02:30Z","timestamp":1610708550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex"],"prefix":"10.1038","volume":"11","author":[{"given":"Charles E.","family":"Bullerwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Pierre","family":"Robichaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre M. L.","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Wajnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwin","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simi","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Crapoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Ouellette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"81000_CR1","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1093\/emboj\/17.8.2319","volume":"17","author":"SL Nutt","year":"1998","unstructured":"Nutt, S. L., Morrison, A. M., D\u00f6rfler, P., Rolink, A. & Busslinger, M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17, 2319\u20132333 (1998).","journal-title":"EMBO J."},{"key":"81000_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","volume":"111","author":"J Medvedovic","year":"2011","unstructured":"Medvedovic, J., Ebert, A., Tagoh, H. & Busslinger, M. Pax5: a master regulator of B cell development and leukemogenesis. Adv. Immunol. 111, 179\u2013206 (2011).","journal-title":"Adv. Immunol."},{"key":"81000_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2006.02.003","volume":"24","author":"K-P Nera","year":"2006","unstructured":"Nera, K.-P. et al. Loss of Pax5 promotes plasma cell differentiation. Immunity 24, 283\u2013293 (2006).","journal-title":"Immunity"},{"key":"81000_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nature06159","volume":"449","author":"C Cobaleda","year":"2007","unstructured":"Cobaleda, C., Jochum, W. & Busslinger, M. Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449, 473\u2013477 (2007).","journal-title":"Nature"},{"key":"81000_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1074-7613(02)00472-7","volume":"17","author":"A Souabni","year":"2002","unstructured":"Souabni, A., Cobaleda, C., Schebesta, M. & Busslinger, M. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17, 781\u2013793 (2002).","journal-title":"Immunity"},{"key":"81000_CR6","first-page":"1716","volume":"59","author":"D Eberhard","year":"1999","unstructured":"Eberhard, D. & Busslinger, M. The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins. Cancer Res. 59, 1716\u20131725 (1999).","journal-title":"Cancer Res."},{"key":"81000_CR7","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1038\/emboj.2011.140","volume":"30","author":"S McManus","year":"2011","unstructured":"McManus, S. et al. The transcription factor Pax5 regulates its target genes by recruiting chromatin-modifying proteins in committed B cells. EMBO J. 30, 2388\u20132404 (2011).","journal-title":"EMBO J."},{"key":"81000_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/j.1349-7006.1988.tb01544.x","volume":"79","author":"H Kamesaki","year":"1988","unstructured":"Kamesaki, H. et al. A novel B cell line from Ki-1-positive diffuse large cell lymphoma. Jpn. J. Cancer Res. 79, 1193\u20131200 (1988).","journal-title":"Jpn. J. Cancer Res."},{"key":"81000_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1073\/pnas.87.2.628","volume":"87","author":"H Ohno","year":"1990","unstructured":"Ohno, H. et al. Molecular analysis of a chromosomal translocation, t(9; 14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen. Proc. Natl. Acad. Sci. USA 87, 628\u2013632 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81000_CR10","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1073\/pnas.93.12.6129","volume":"93","author":"M Busslinger","year":"1996","unstructured":"Busslinger, M., Klix, N., Pfeffer, P., Graninger, P. G. & Kozmik, Z. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl. Acad. Sci. USA 93, 6129\u20136134 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81000_CR11","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1182\/blood.V88.11.4110.4110","volume":"88","author":"S Lida","year":"1996","unstructured":"Lida, S. et al. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88, 4110\u20134117 (1996).","journal-title":"Blood"},{"key":"81000_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1046\/j.1365-2141.1998.00842.x","volume":"102","author":"T Hamada","year":"1998","unstructured":"Hamada, T. et al. Expression of the PAX5\/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin\u2019s lymphoma. Br. J. Haematol. 102, 691\u2013700 (1998).","journal-title":"Br. J. Haematol."},{"key":"81000_CR13","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood.V92.10.3865","volume":"92","author":"AM Morrison","year":"1998","unstructured":"Morrison, A. M. et al. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood 92, 3865\u20133878 (1998).","journal-title":"Blood"},{"key":"81000_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1101\/gad.309583.117","volume":"32","author":"R Li","year":"2018","unstructured":"Li, R. et al. Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming. Genes Dev. 32, 96\u2013111 (2018).","journal-title":"Genes Dev."},{"key":"81000_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"81000_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.23607","volume":"123","author":"C Stresemann","year":"2008","unstructured":"Stresemann, C. & Lyko, F. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int. J. Cancer 123, 8\u201313 (2008).","journal-title":"Int. J. Cancer"},{"key":"81000_CR17","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.4049\/jimmunol.1103039","volume":"188","author":"T Yasuda","year":"2012","unstructured":"Yasuda, T. et al. B cell receptor-ERK1\/2 signal cancels PAX5-dependent repression of BLIMP1 through PAX5 phosphorylation: a mechanism of antigen-triggering plasma cell differentiation. J. Immunol. 188, 6127\u20136134 (2012).","journal-title":"J. Immunol."},{"key":"81000_CR18","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.18632\/oncotarget.6920","volume":"7","author":"H Tomita","year":"2016","unstructured":"Tomita, H., Tanaka, K., Tanaka, T. & Hara, A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget 7, 11018\u201311032 (2016).","journal-title":"Oncotarget"},{"key":"81000_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12026-013-8464-1","volume":"57","author":"H Muta","year":"2013","unstructured":"Muta, H. & Podack, E. R. CD30: from basic research to cancer therapy. Immunol. Res. 57, 151\u2013158 (2013).","journal-title":"Immunol. Res."},{"issue":"D1","key":"81000_CR20","doi-asserted-by":"publisher","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","volume":"45","author":"H Mi","year":"2017","unstructured":"Mi, H. et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 45(D1), D183\u2013D189 (2017).","journal-title":"Nucleic Acids Res."},{"key":"81000_CR21","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1128\/MCB.23.19.6944-6957.2003","volume":"19","author":"NA Barlev","year":"2003","unstructured":"Barlev, N. A. et al. A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription. Mol. Cell Biol. 19, 6944\u20136957 (2003).","journal-title":"Mol. Cell Biol."},{"key":"81000_CR22","doi-asserted-by":"publisher","first-page":"11258","DOI":"10.1073\/pnas.0809485106","volume":"106","author":"H Gao","year":"2009","unstructured":"Gao, H. et al. Opposing effects of SWI\/SNF and Mi-2\/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc. Natl. Acad. Sci. U. S. A. 106, 11258\u201311263 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"81000_CR23","doi-asserted-by":"publisher","first-page":"14137","DOI":"10.1074\/jbc.M110.176289","volume":"286","author":"T He","year":"2011","unstructured":"He, T. et al. Histone acetyltransferase p300 acetylates Pax5 and strongly enhances Pax5-mediated transcriptional activity. J. Biol. Chem. 286, 14137\u201314145 (2011).","journal-title":"J. Biol. Chem."},{"key":"81000_CR24","doi-asserted-by":"publisher","first-page":"11156","DOI":"10.1074\/jbc.M111763200","volume":"277","author":"AV Emelyanov","year":"2002","unstructured":"Emelyanov, A. V., Kovac, C. R., Sepulveda, M. A. & Birshtein, B. K. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 277, 11156\u201311164 (2002).","journal-title":"J. Biol. Chem."},{"key":"81000_CR25","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1093\/emboj\/19.10.2292","volume":"19","author":"D Eberhard","year":"2000","unstructured":"Eberhard, D., Jim\u00e9nez, G., Heavey, B. & Busslinger, M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19, 2292\u20132303 (2000).","journal-title":"EMBO J."},{"key":"81000_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1365-2567.2002.01456.x","volume":"106","author":"M Milili","year":"2002","unstructured":"Milili, M., Gauthier, L., Veran, J., Mattei, M.-G. & Schiff, C. A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes. Immunology 106, 447\u2013455 (2002).","journal-title":"Immunology"},{"key":"81000_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.embor.7400089","volume":"5","author":"Y Linderson","year":"2004","unstructured":"Linderson, Y. et al. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes. EMBO Rep. 5, 291\u2013296 (2004).","journal-title":"EMBO Rep."},{"key":"81000_CR28","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1074\/jbc.M305418200","volume":"279","author":"S Merluzzi","year":"2004","unstructured":"Merluzzi, S. et al. CD40 stimulation induces Pax5\/BSAP and EBF activation through a APE\/Ref-1-dependent redox mechanism. J. Biol. Chem. 279, 1777\u20131786 (2004).","journal-title":"J. Biol. Chem."},{"key":"81000_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.immuni.2010.04.013","volume":"32","author":"T Treiber","year":"2010","unstructured":"Treiber, T. et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. Immunity 32, 714\u2013725 (2010).","journal-title":"Immunity"},{"key":"81000_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1128\/MCB.19.1.392","volume":"19","author":"P Akerblad","year":"1999","unstructured":"Akerblad, P., Rosberg, M., Leanderson, T. & Sigvardsson, M. The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor. Mol. Cell. Biol. 19, 392\u2013401 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"81000_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/leu.2012.280","volume":"27","author":"V Bohle","year":"2013","unstructured":"Bohle, V., D\u00f6ring, C., Hansmann, M. L. & K\u00fcppers, R. Role of early B-cell factor 1(EBF1) in Hodgkin lymphoma. Leukemia 27, 671\u2013679 (2013).","journal-title":"Leukemia"},{"key":"81000_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ccr.2014.03.008","volume":"25","author":"H Liu","year":"2014","unstructured":"Liu, H. et al. Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4. Cancer Cell 25, 530\u2013542 (2014).","journal-title":"Cancer Cell"},{"key":"81000_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrc3929","volume":"15","author":"RC Rao","year":"2015","unstructured":"Rao, R. C. & Dou, Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Nat. Rev. Cancer 15, 334\u2013346 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"81000_CR34","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1093\/nar\/28.14.2741","volume":"28","author":"MS Lechner","year":"2000","unstructured":"Lechner, M. S., Levitan, I. & Dressler, G. R. PTIP, a novel BRCT domain-containing protein interacts with Pax2 and is associated with active chromatin. Nucleic Acids Res. 28, 2741\u20132751 (2000).","journal-title":"Nucleic Acids Res."},{"key":"81000_CR35","doi-asserted-by":"publisher","first-page":"20395","DOI":"10.1074\/jbc.M701574200","volume":"282","author":"YW Cho","year":"2007","unstructured":"Cho, Y. W. et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282, 20395\u201320406 (2007).","journal-title":"J. Biol. Chem."},{"key":"81000_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.devcel.2007.09.004","volume":"13","author":"SR Patel","year":"2007","unstructured":"Patel, S. R., Kim, D., Levitan, I. & Dressler, G. R. The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev. Cell 13, 580\u2013592 (2007).","journal-title":"Dev. Cell"},{"key":"81000_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014).","journal-title":"Science"},{"key":"81000_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12033-012-9528-5","volume":"53","author":"W Denning","year":"2013","unstructured":"Denning, W. et al. Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations. Mol. Biotechnol. 53, 308\u2013314 (2013).","journal-title":"Mol. Biotechnol."},{"key":"81000_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10 (2011).","journal-title":"EMBnet.journal"},{"key":"81000_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"81000_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"81000_CR42","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. 1000 genome project data processing subgroup. The sequence alignment\/map format and SAM tools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"81000_CR43","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"81000_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"81000_CR45","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2018). http:\/\/www.R-project.org\/."},{"key":"81000_CR46","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/bioinformatics\/btp373","volume":"25","author":"DC Koboldt","year":"2009","unstructured":"Koboldt, D. C. et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283\u20132285 (2009).","journal-title":"Bioinformatics"},{"key":"81000_CR47","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","volume":"5","author":"JK Eng","year":"1994","unstructured":"Eng, J. K., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976\u2013989 (1994).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"81000_CR48","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1021\/pr500202e","volume":"13","author":"V Dorfer","year":"2014","unstructured":"Dorfer, V. et al. MS Amanda, a universal identification algorithm optimized for high accuracy tandem mass spectra. J. Proteome Res. 13, 3679\u20133684 (2014).","journal-title":"J. Proteome Res."},{"key":"81000_CR49","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","volume":"75","author":"AI Nesvizhskii","year":"2003","unstructured":"Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A. Statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646\u20134658 (2003).","journal-title":"Anal. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81000-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81000-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:04:39Z","timestamp":1670033079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81000-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["81000"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-81000-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1537"}}